Business Description
Suzhou Novoprotein Scientific Co Ltd
ISIN : CNE100005NZ4
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 14.96 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -4.29 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 11.24 | |||||
Beneish M-Score | -2.71 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | 151.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.02 | |||||
9-Day RSI | 56.77 | |||||
14-Day RSI | 57.71 | |||||
6-1 Month Momentum % | -7.42 | |||||
12-1 Month Momentum % | -39.1 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 23.75 | |||||
Quick Ratio | 22.83 | |||||
Cash Ratio | 13.12 | |||||
Days Inventory | 677.61 | |||||
Days Sales Outstanding | 178.7 | |||||
Days Payable | 143.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.48 | |||||
Forward Dividend Yield % | 1.48 | |||||
5-Year Yield-on-Cost % | 1.48 | |||||
3-Year Average Share Buyback Ratio | -10.1 | |||||
Shareholder Yield % | 1.58 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 65.53 | |||||
Operating Margin % | -17.8 | |||||
Net Margin % | -6.1 | |||||
FCF Margin % | -2.23 | |||||
ROE % | -0.39 | |||||
ROA % | -0.37 | |||||
ROIC % | -1.39 | |||||
ROC (Joel Greenblatt) % | -2.97 | |||||
ROCE % | -0.79 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 132.33 | |||||
PS Ratio | 18.33 | |||||
PB Ratio | 1.13 | |||||
Price-to-Tangible-Book | 1.14 | |||||
Price-to-Operating-Cash-Flow | 50.76 | |||||
EV-to-EBIT | -74.59 | |||||
EV-to-EBITDA | -74.59 | |||||
EV-to-Revenue | 9.53 | |||||
EV-to-FCF | -440.25 | |||||
Price-to-Graham-Number | 2.59 | |||||
Price-to-Net-Current-Asset-Value | 1.28 | |||||
Price-to-Net-Cash | 2.47 | |||||
Earnings Yield (Greenblatt) % | -1.34 | |||||
FCF Yield % | -0.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Suzhou Novoprotein Scientific Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 138.157 | ||
EPS (TTM) (Â¥) | -0.13 | ||
Beta | 0 | ||
Volatility % | 43.58 | ||
14-Day RSI | 57.71 | ||
14-Day ATR (Â¥) | 1.750385 | ||
20-Day SMA (Â¥) | 32.692 | ||
12-1 Month Momentum % | -39.1 | ||
52-Week Range (Â¥) | 28.56 - 60.5 | ||
Shares Outstanding (Mil) | 70.18 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Suzhou Novoprotein Scientific Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Suzhou Novoprotein Scientific Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Suzhou Novoprotein Scientific Co Ltd Frequently Asked Questions
What is Suzhou Novoprotein Scientific Co Ltd(SHSE:688137)'s stock price today?
When is next earnings date of Suzhou Novoprotein Scientific Co Ltd(SHSE:688137)?
Does Suzhou Novoprotein Scientific Co Ltd(SHSE:688137) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |